Company & Sponsor Intelligence

Oregon Health and Science University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials14
Recruiting2
Completed9
Countries1

Therapeutic footprint

alzheimersautismmovement_disordersmultiple_sclerosispain_neuropathyparkinsons

Indexed studies

NCT01579669Partnering With Autistic Adults to Improve Healthcare
autism · United States
NA
NCT01058941Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease
alzheimers · United States
PHASE1, PHASE2
NCT02206620Effects of Cholinergic Augmentation on Measures of Balance and Gait
parkinsons · United States
PHASE2
NCT04686838REmote Assessment and Dynamic Response Intervention II
alzheimers · United States
NA
NCT05260515Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
alzheimers ·
PHASE1, PHASE2
NCT00663520Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
pain_neuropathy · United States
COMPLETED
NCT04468932Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
movement_disorders · United States
NA
NCT02760056Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
multiple_sclerosis · United States
PHASE1
NCT03599726Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
parkinsons · United States
EARLY_PHASE1
NCT01003002Natural History of Levodopa-Induced Dyskinesia (LID)
parkinsons · United States
WITHDRAWN
NCT04542109REmote Assessment and Dynamic Response Intervention
alzheimers · United States
NA
NCT06908187Opt-In Early Pilot Study
autism · United States
NA

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →